Germany · Delayed Price · Currency is EUR Evotec SE Statistics
Total Valuation
Evotec SE has a market cap or net worth of EUR 605.06 million. The enterprise value is 615.34 million.
| Market Cap | 605.06M |
| Enterprise Value | 615.34M |
Important Dates
The last earnings date was Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Evotec SE has 177.75 million shares outstanding. The number of shares has increased by 0.08% in one year.
| Current Share Class | 177.75M |
| Shares Outstanding | 177.75M |
| Shares Change (YoY) | +0.08% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 0.23% |
| Owned by Institutions (%) | 32.63% |
| Float | 135.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.84 |
| PB Ratio | 0.91 |
| P/TBV Ratio | 1.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.86 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.33, with a Debt / Equity ratio of 0.71.
| Current Ratio | 2.33 |
| Quick Ratio | 2.02 |
| Debt / Equity | 0.71 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.92 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -26.08% and return on invested capital (ROIC) is -22.13%.
| Return on Equity (ROE) | -26.08% |
| Return on Assets (ROA) | -5.39% |
| Return on Invested Capital (ROIC) | -22.13% |
| Return on Capital Employed (ROCE) | -11.56% |
| Weighted Average Cost of Capital (WACC) | 6.27% |
| Revenue Per Employee | 160,790 |
| Profits Per Employee | -44,171 |
| Employee Count | 4,461 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 17.96 |
Taxes
In the past 12 months, Evotec SE has paid 13.25 million in taxes.
| Income Tax | 13.25M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.12% in the last 52 weeks. The beta is 1.26, so Evotec SE's price volatility has been higher than the market average.
| Beta (5Y) | 1.26 |
| 52-Week Price Change | -46.12% |
| 50-Day Moving Average | 4.13 |
| 200-Day Moving Average | 5.07 |
| Relative Strength Index (RSI) | 38.23 |
| Average Volume (20 Days) | 804,020 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Evotec SE had revenue of EUR 717.28 million and -197.05 million in losses. Loss per share was -1.11.
| Revenue | 717.28M |
| Gross Profit | 60.71M |
| Operating Income | -145.86M |
| Pretax Income | -183.80M |
| Net Income | -197.05M |
| EBITDA | -73.18M |
| EBIT | -145.86M |
| Loss Per Share | -1.11 |
Balance Sheet
The company has 465.59 million in cash and 475.87 million in debt, with a net cash position of -10.28 million or -0.06 per share.
| Cash & Cash Equivalents | 465.59M |
| Total Debt | 475.87M |
| Net Cash | -10.28M |
| Net Cash Per Share | -0.06 |
| Equity (Book Value) | 665.58M |
| Book Value Per Share | 3.75 |
| Working Capital | 416.43M |
Cash Flow
In the last 12 months, operating cash flow was -115.03 million and capital expenditures -48.19 million, giving a free cash flow of -163.21 million.
| Operating Cash Flow | -115.03M |
| Capital Expenditures | -48.19M |
| Depreciation & Amortization | 72.68M |
| Net Borrowing | -16.97M |
| Free Cash Flow | -163.21M |
| FCF Per Share | -0.92 |
Margins
Gross margin is 8.46%, with operating and profit margins of -20.33% and -27.47%.
| Gross Margin | 8.46% |
| Operating Margin | -20.33% |
| Pretax Margin | -25.62% |
| Profit Margin | -27.47% |
| EBITDA Margin | -10.20% |
| EBIT Margin | -20.33% |
| FCF Margin | n/a |
Dividends & Yields
Evotec SE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.08% |
| Shareholder Yield | -0.08% |
| Earnings Yield | -32.57% |
| FCF Yield | -26.97% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for Evotec SE is 4.59, which is 34.84% higher than the current price. The consensus rating is "Hold".
| Price Target | 4.59 |
| Price Target Difference | 34.84% |
| Analyst Consensus | Hold |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | -0.15% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on August 18, 2000. It was a forward split with a ratio of 2.
| Last Split Date | Aug 18, 2000 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Evotec SE has an Altman Z-Score of 0.3 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.3 |
| Piotroski F-Score | 4 |